Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
IEEE Transactions on Visualization and Computer Graphics|November 23, 2016
An Evaluation of Visual Search Support in MapsRudolf Netzel, Marcel Hlawatsch, Michael Burch, et al.
Nucleic Acids Research|January 8, 2016
Expanding the CRISPR imaging toolset with Staphylococcus aureus Cas9 for simultaneous imaging of multiple genomic lociBaohui Chen, Jeffrey Hu, Ricardo Almeida, et al.
Nature Medicine|March 8, 2016
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancerRoman Camarda, Alicia Y Zhou, Rebecca A Kohnz, et al.
Plos Genetics|July 3, 2015
Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in ZebrafishKimberley J Evason, Macrina T Francisco, Vladislava Juric, et al.
EMBO Reports|February 22, 2017
MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancerBrittany Anderton, Roman Camarda, Sanjeev Balakrishnan, et al.
Nature|September 30, 2015
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cellsDevon A Lawson, Nirav R Bhakta, Kai Kessenbrock, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibitionLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Cell Reports|March 12, 2020
MYC Dysregulates Mitosis, Revealing Cancer VulnerabilitiesJulia Rohrberg, Daniel Van de Mark, Meelad Amouzgar, et al.
Communications Medicine|February 20, 2024
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse modelsLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Nature Medicine|November 8, 2016
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expressionDai Horiuchi, Roman Camarda, Alicia Y Zhou, et al.
Pageof 2